BHC Stock Price, Chart, Stats & News

Bausch Health Companies Inc.
Save
1.93B
Market cap
–
Current P/E
1.22x
Forward P/E
BHC chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 68.33% |
Operating margin | 20.07% |
Pretax margin | 3.57% |
Net margin | 1.51% |
Effective tax rate | 67.81% |
ROA | 0.59% |
ROE | -20.27% |
D/E | -38.35x |
Interest coverage ratio | 1.37x |
BHC valuation
P/E | – |
P/S | 0.18x |
P/B | -3.36x |
P/CF | 1.33x |
P/FCF | 1.87x |
P/OCF | 1.33x |
PEG | -0.21x |
EV multiple | -6.09x |
About
Bausch Health Companies Inc., together with its associated entities, is engaged in the development, manufacturing, and commercialization of a diverse portfolio of pharmaceutical products, medical devices, and over-the-counter remedies. Its primary therapeutic focus areas include ophthalmology, digestive health, and dermatology. The enterprise conducts its operations through five principal divisions: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products.
Similar securities
Based on sector and market capitalization
Report issue











